1. Home
  2. AKBA vs BCML Comparison

AKBA vs BCML Comparison

Compare AKBA & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.38

Market Cap

380.4M

Sector

Health Care

ML Signal

HOLD

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$28.99

Market Cap

331.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKBA
BCML
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
380.4M
331.4M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
AKBA
BCML
Price
$1.38
$28.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$5.75
$34.00
AVG Volume (30 Days)
2.5M
15.5K
Earning Date
05-07-2026
04-16-2026
Dividend Yield
N/A
4.10%
EPS Growth
93.94
3.81
EPS
N/A
2.18
Revenue
N/A
N/A
Revenue This Year
N/A
$13.71
Revenue Next Year
N/A
$5.25
P/E Ratio
N/A
$13.56
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$22.22
52 Week High
$4.08
$33.15

Technical Indicators

Market Signals
Indicator
AKBA
BCML
Relative Strength Index (RSI) 51.06 46.04
Support Level $1.30 $26.91
Resistance Level $1.55 $30.66
Average True Range (ATR) 0.07 0.88
MACD 0.00 0.04
Stochastic Oscillator 50.70 41.89

Price Performance

Historical Comparison
AKBA
BCML

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: